摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-二氯丙酰胺 | 19433-84-2

中文名称
2,3-二氯丙酰胺
中文别名
2,3二氯丙酸酯
英文名称
2,3-dichloropropionamide
英文别名
α,β-dichloropropionamide;2,3-dichloropropanamide
2,3-二氯丙酰胺化学式
CAS
19433-84-2
化学式
C3H5Cl2NO
mdl
MFCD00040311
分子量
141.985
InChiKey
SQGUQSRDWXDLIH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    106 °C

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    7
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.666
  • 拓扑面积:
    43.1
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2924199090

反应信息

  • 作为反应物:
    描述:
    2,3-二氯丙酰胺sodium hydroxide对苯二酚 作用下, 以 为溶剂, 生成 2-氯丙烯酰胺
    参考文献:
    名称:
    Bogolyubskaya, L. T.; Bogolyubskii, A. V., Journal of Organic Chemistry USSR (English Translation), 1984, p. 1674 - 1675
    摘要:
    DOI:
  • 作为产物:
    描述:
    参考文献:
    名称:
    Vitamin D–receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis
    摘要:
    Background & Aims: Hepatic osteodystrophy is a complication of primary biliary cirrhosis (PBC). Allelic polymorphisms of the vitamin D receptor (VDR) gene are related to bone mineral density (BMD) in normal cohorts and those with primary osteoporosis. We sought to establish the prevalence of reduced bone mass in PBC, correlate BMD with VDR gene polymorphisms, and identify risk factors for the development of hepatic osteodystrophy. Methods: Seventy-two female patients with PBC were evaluated prospectively. Clinical information, BMD assessment, disease severity, and osteoporosis risk factors were documented, and multivariate regression modeling was performed. Results: Twenty-four percent of the patients were osteoporotic at the lumbar spine and 32% at the femur. Severe bone loss (z score <-2.0) occurs 4 times more frequently in patients with PBC compared with controls. Body weight (P = 0.003) and postmenopausal status (P = 0.012) correlated independently with BMD. VDR genotype (P = 0.01) correlated with lower BMD at the spine only. Conclusions: Osteoporosis is a common complication of PBC, VDR genotype predicts lower BMD in patients with PBC. Studies are warranted to investigate the mechanism(s) by which VDR as well as other candidate genes may contribute to the development of hepatic osteodystrophy in PBC.
    DOI:
    10.1016/s0016-5085(00)70423-9
点击查看最新优质反应信息

文献信息

  • Aminobenzenesulfonyl-acrylamides
    申请人:Sanitized, Inc.
    公开号:US03976668A1
    公开(公告)日:1976-08-24
    A method of preventing the growth of microorganisms by contacting the microorganisms with a bioactive compound which may be described by one of the following formulas: H[(C.sub.n H.sub.2n) - A.sub.p - (C.sub.m H.sub.2m)CO].sub.k.sup.. NH C.sub.6 H.sub.4 SO.sub. 2 - CH = CH - X; ##SPC1## or R.sub.3 SO.sub.2 CH = CH - CONH.sub.2 in which A is benzene or napthalene, X is --CN, --CONH.sub.2, --COOR, --SO.sub.2 R, --SO.sub.3 R, --NO.sub.2 or --COR, R.sub.1 is an amino, acylamido or nitro group, R.sub.2 is hydrogen or a lower alkyl group, R.sub.3 is an alkyl, substituted alkyl, aryl, substituted aryl, cycloalkyl, or substituted cycloalkyl or a heterocyclic group and where n = 0 to 18, m = 0 to 18, m + n = 24 or less, p = 0 or 1 and k = 0 or 1.
    一种抑制微生物生长的方法,通过将微生物生物活性化合物接触,该生物活性化合物可以用以下公式之一描述:H [(C.sub.n H.sub.2n) - A.sub.p -(C.sub.m H.sub.2m)CO] .sub.k.sup.。 NH C.sub.6 H.sub.4 SO.sub. 2 - CH = CH - X; ## SPC1 ## 或 R.sub.3 SO.sub.2 CH = CH - CONH.sub.2,其中A是苯或,X是-CN,-CONH.sub.2,-COOR,-SO.sub.2 R,-SO.sub.3 R,-NO.sub.2或-COR,R.sub.1是基,酰胺基或硝基,R.sub.2是氢或较低的烷基,R.sub.3是烷基,取代烷基,芳基,取代芳基,环烷基或取代环烷基或杂环基,其中n = 0至18,m = 0至18,m + n = 24或更少,p = 0或1,k = 0或1。
  • Acylamides of beta-cyano-ethenesulfonyl substituted aminoarenes
    申请人:Sanitized Incorporated
    公开号:US03943154A1
    公开(公告)日:1976-03-09
    Acylamides of .beta.-X-ethenesulfonyl substituted aminoarenes in which the acyl moiety is an organic sulfonic, sulfinic or sulfenic acid group; an organic phosphoric, thiophosphoric, phosphonic, thiophosphonic, or phosphinic acid group; or the sulfinyl group (O=S=). Compounds within the designated class of materials are bioactive, i.e., they control the growth and activity of varying types of plant and animal organisms, e.g., microorganisms or the like.
    这段话的中文翻译如下: 这些化合物属于β-X-乙烯基磺酰取代芳烃酰胺类化合物,其中酰基是有机磺酸、亚磺酸或亚砜酸基团;有机磷酸硫代磷酸膦酸膦酸膦酸酰基团;或亚砜基团(O=S=)。这一类物质具有生物活性,即它们可以控制各种植物和动物生物体的生长和活动,例如微生物等。
  • Efficient .alpha.-halogenation of acyl chlorides by N-bromosuccinimide, N-chlorosuccinimide, and molecular iodine
    作者:David N. Harpp、L. Q. Bao、Catherine J. Black、John G. Gleason、Roger A. Smith
    DOI:10.1021/jo00911a026
    日期:1975.11
  • Kinetics and mechanism of chlorine addition to acrylic acid and its derivatives with special reference to the nature of the transition state
    作者:R. M. Subramanian、R. Ganesan
    DOI:10.1021/jo01294a051
    日期:1980.3
  • BOGOLYUBSKAYA, L. T.;BOGOLYUBSKIJ, A. V., ZH. ORGAN. XIMII, 1984, 20, N 9, 1835-1837
    作者:BOGOLYUBSKAYA, L. T.、BOGOLYUBSKIJ, A. V.
    DOI:——
    日期:——
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
hnmr
mass
cnmr
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸